Abstract
In order to examine the relationship between local adenosine concentrations before, during, and after ischemia and the extent of ischemic myocardial damage, measurements of interstitial fluid (ISF) nucleosides were made using microdialysis probes implanted in the ischemic region of isoflurane anesthetized Micropigs undergoing 60′ coronary artery occlusion (CAO) and 3h of reperfusion (REP). Nucleoside concentrations in the dialysate collected from the microdialysis probes were used as an index of ISF levels. Dialysate nucleoside concentrations (ADO, inosine and hypoxanthine), myocardial infarct size, and myocardial blood flow (MBF) were determined in control animals (n=6), animals preconditioned with a single 10′ cycle of CAO and REP (PC, n=6), and those treated with the adenosine deaminase inhibitor pentostatin (n=6, 0.2 mg/Kg IV 30′ prior to CAO). The brief PC occlusion resulted in a transient but significant increase in dialysate ADO (6.7±1.8 μM vs. 0.67±0.1 μM at baseline). Pentostatin administration had no significant effect on either dialysate nucleosides or MBF at baseline. During the 60′ CAO, dialystate ADO increased in control animals. In PC animals, however, dialysate ADO during CAO was lower than control. Pretreatment with pentostatin resulted in a six-fold augmentation in dialysate ADO during the 60 min CAO when compared to the control values (110.62±30.2 μM vs. 16.31±2.1 μM at 60 min of ischemia). Pentostatin also resulted in a significant reduction in the accumulation of inosine and hypoxanthine, indicating inhibition of adenosine deaminase activity. There were no significant differences in MBF between groups at any time point. Following 3 h REP, infarct size was 35.4±5.5%, 8.1±1.5% and 8.3±1.8% of the region at control, PC, and pentostatin groups, respectively. These data suggest that marked increase in ISF ADO during CAO, may be as effective in reducing INF as a modest increase in ISF ADO prior to prolonged CAO.
Similar content being viewed by others
References
Abd-Elfattah AS, Ding M, Dyke CM, Wechsler AS (1993) Protection of the stunned myocardium: selective nucleoside transport blocker administered after 20 minutes of ischemia augments recovery of ventricular function. Circulation 88 [part 2]: 336–343
Belardinelli L, Linden J, Berne RM (1989) The cardiac effects of adenosine. Prog Cardiovasc Dis 32: 73–97
Dorheim T, Hoffman A, Van Wylen DGL, Mentzer RM (1991) Enhanced interstitial fluid adenosine attenuates myocardial stunning. Surgery 110: 136–145
Heymann MA, Payne DB, Hoffman JIE, Rudolph AM (1977) Blood flow measurements with radionuclide-labled particles. Prog Cardiovasc Dis 20: 55–79
Homeister JW, Hoff PT, Fletcher DD, Lucchesi BR (1990) Combined adenosine and lidocaine administration limits reperfusion injury. Circulation 82: 595–608
Hudspeth DA, Williams MW, Zhao Z-Q, Sato H, Nakanishi K, McGee DS, Hammon JW, Vinten-Johansen J, Van Wylen DGL (1994) Pretreatment with pentostatin augments interstitial fluid adenosine and prevents post-ischemic dysfunction in canine hearts protected with blood cardioplegia. Ann Thorac Surg 58: 719–727
Itoya M, Miura T, Sakamoto J, Urabe K, Iimura O (1994) Nucleoside transport inhibitors enhance the infarct limiting effects of ischemic preconditioning. J Cardiovasc Pharmacol 24: 846–852
Kirkeboen KA, Ilebekk A, Tonnessen T, Leistad E, Naess PA, Christensen G, Aksnes G (1994) Cardiac contractile function following repetitive brief ischemia: effects of nucleoside transport inhibition. Am J Physiol 267: H57-H65
Klohs WD, Kraker AJ (1992) Pentostatin: Future directions. Pharmacol Rev 44: 459–477
Lasley RD, Konyn PJ, Hegge JO, Mentzer RM (1995) Effects of ischemic and adenosine preconditioning on interstitial fluid adenosine and myocardial infarct size. Am J Physiol 38: H1460-H1466
Li GC, Vasquez JA, Gallagher KP, Lucchesi BR (1990) Myocardial protection with preconditioning. Circulation 82: 609–619
Li Y, Kloner RA (1993) Adenosine deaminase inhibition is not cardioprotective in the rat. Am Heart J 126: 1293–1298
Masuda M, Demeulemeester A, Chang-Chun C, Hendrikx M, Van Belle H, Flameng W (1991) Cardioprotective effects of nucleoside transport inhibition in rabbits. Ann Thorac Surg 52: 1300–1305
Maxwell MP, Hearse DJ, Yellon DM (1987) Species variation in the coronary collateral circulation during regional myocardial ischemia: a critical determinant of the rate of evolution and extent of myocardial infarction. Cardiovasc Res 21: 737–746
McClanahan TB, Ignasiak D, Martin BJ, Mertz TE, Gallagher KP (1995) Effect of adenosine deaminase inhibition with pentostatin on myocardial stunning in dogs. Basic Res Cardiol 90: 176–183
McClanahan TB, Metz TE, Martin BJ, Gallagher KP (1994) Pentostatin reduces infarct size in pigs only when combined with mild hypothermia (abstract). Circulation I-478
Murray CE, Richard VJ, Reimer KA, Jennings RB (1990) Ischemic preconditioning slow energy metabolism and delays ultrastructural damage during a sustained ischemic episode. Circ Res 66: 913–931
Romson JL, Hook BG, Rigot VH, Shork MA, Swanson DP, Lucchesi BR (1982) The effect of ibuprofen on the accumulation of indium-111 labeled platelets and leukocytes in experimental myocardial infarction. Circulation 66: 1002–1022
Sandhu GS, Burrier AC, Janero DR (1993) Adenosine deaminase inhibitors attenuate ischemic injury and preserve energy balance in the isolated guinea pig heart. Am J Physiol 265: H1249–1256
Schulz R, Rose J, Post H, Heusch G (1995) Involvement of endogenous edenosine in ischaemic preconditioning in swine. Pflügers Arch 430: 273–282
Schulz R, Rose J, Post H, Heusch G (1995) Regional short-term myocardial hibernation in swine does not involve endogenous adenosine or KATP channels. Am J Physiol 268: H2294-H2301
Silva PH, Dillon D, Van Wylen DGL (1995) Adenosine deaminase inhibition augments interstitial adenosine but does not attenuate myocardial infarction. Cardiovasc Res 29: 616–623
Sparks HV, Bardenheuer H (1986) Regulation of adenosine formation by the heart. Circ Res 58: 193–200
Toombs CF, McGee DS, Johnston WE, Vinten-Johansen J (1993) Protection from ischaemic-reperfusion injury with adenosine pretreatment is reversed by inhibition of ATP sensitive potassium channels. Cardiovasc Res 27: 623–629
Toombs CF, McGee DS, Johnston WE, Vinten-Johansen J (1992) Myocardial protective effects of adenosine: infarct size reduction with pretreatment and continued receptor stimulation during ischemia. Circulation 86: 986–994
Van Winkle DM, Chien GL, Wolff RA, Soifer BE, Kuzume K, Davis RF (1994) Cardioprotection provided by adenosine receptor activation is abolished by blockade of the KATP channel. Am J Physiol 266 (35): H1-H11
Van Wylen DGL (1994) Effect of ischemic preconditioning on interstitial purine metabolite and lactate accumulation during myocardial ischemia. Circulation 89: 2283–2289
Van Wylen DGL, Willis J, Sodhi J, Weiss RJ, Lasley RD, Mentzer RM (1990) Cardiac microdialysis to estimate interstitial adenosine and coronary blood flow. Am J Physiol 258: H1642-H1649
Woo PWK, Dion HW, Lange SM, Dahl LF, Durham LJ (1974) A novel adenosine and Ara-A deaminase inhibitor, (R)-3-(2-deoxy-beta-D-erythropentofuranosyl)-3,6,7,8 tetrahydroimidazo (4,5-d) (1,3) diazepin-8-ol. J Heterocycl Chem 11: 641–643
Wu S, Fu L, Koke JR, Bittar N (1987) Contractility, ATP, and creatine phosphate during myocardial ischemia and reperfusion: the effects of adenosine and inhibition of adenosine catabolism in the dog heart. Cytobios 50: 7–12
Yao Z, Gross G (1994) A comparison of adenosine-induced cardioprotection and ischemic preconditioning in dogs. Efficacy, time course and role of KATP channels. Circulation 89: 1229–1236
Zhu Q, Chen S, Zou C (1990) Protective effects of an adenosine deaminase inhibitor on ischemia-reperfusion injury in the isolated rat heart. Am J Physiol 259: H835–838
Author information
Authors and Affiliations
Corresponding author
Additional information
Supported in part by NIH grant R01 HL32043
Rights and permissions
About this article
Cite this article
Martin, B.J., McClanahan, T.B., Van Wylen, D.G.L. et al. Effects of ischemia, preconditioning, and adenosine deaminase inhibition on interstitial adenosine levels and infarct size. Basic Res Cardiol 92, 240–251 (1997). https://doi.org/10.1007/BF00788519
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00788519